Transcripts Virbac Deutsche Boerse AG

Stocks

V16

FR0000031577

Pharmaceuticals

Market Closed - Deutsche Boerse AG 17:25:02 01/09/2026 +04			After hours 23:59:00
320.50 ^EUR	+0.16%		321.25	+0.23%

08-20	Cancer vaccines finally garner the spotlight
07-29	Virbac, without the alibi

Transcripts

03-18	Virbac SA, 2025 Earnings Call, Mar 18, 2026
15/09/25	Virbac SA, H1 2025 Earnings Call, Sep 15, 2025
14/03/25	Virbac SA, 2024 Earnings Call, Mar 14, 2025
16/09/24	Virbac SA, H1 2024 Earnings Call, Sep 16, 2024
20/03/24	Virbac SA, 2023 Earnings Call, Mar 20, 2024
09/10/23	Virbac SA, H1 2023 Earnings Call, Oct 09, 2023
24/03/23	Virbac SA, 2022 Earnings Call, Mar 24, 2023
18/10/22	Virbac SA Provides Revenue Guidance for the Year 2022	CI
16/09/22	Virbac SA, H1 2022 Earnings Call, Sep 16, 2022
23/03/22	Virbac SA, 2021 Earnings Call, Mar 23, 2022
19/01/22	Virbac SA Provides Revenue Guidance for the Year 2022	CI
16/09/21	Virbac SA, H1 2021 Earnings Call, Sep 16, 2021
15/09/21	Virbac SA Provides Revenue Guidance for the Year 2021	CI
15/04/21	Virbac SA Revises Earnings Guidance for the Year 2021	CI
18/03/21	Virbac SA, 2020 Earnings Call, Mar 18, 2021
17/03/21	Virbac SA Provides Earnings Guidance for the Year 2021	CI
19/01/21	Virbac SA Provides Revenue Guidance for the Year 2021	CI
17/09/20	Virbac SA, H1 2020 Earnings Call, Sep 17, 2020
17/03/20	Virbac SA, 2019 Earnings Call, Mar 17, 2020
17/03/20	Virbac SA Provides Earnings Guidance for the Year 2020	CI
17/01/20	Virbac SA Announces Unaudited Consolidated Revenue Results for the Fourth Quarter and Full Year of 2019; Provides Group Revenue Guidance for the Fiscal 2020	CI
17/09/19	Virbac SA, H1 2019 Earnings Call, Sep 17, 2019
16/09/19	Virbac SA Announces Earnings Guidance for the Year 2019	CI
16/07/19	Virbac Reports Unaudited Consolidated Revenue Results for Second Quarter and Half Year Ended June 2019; Provides Revenue Guidance for the Year 2019	CI
19/03/19	Virbac SA, 2018 Earnings Call, Mar 19, 2019